PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
|Articles|July 2, 2019
- Pharmaceutical Technology-07-02-2019
- Volume 43
- Issue 7
Planetary Dual Dispersers and Advanced Discharge Systems
The Planetary Dual Disperser is the newest addition to the Ross planetary mixing line of industrial mixers.
The Planetary Dual Disperser (PDDM) is the newest addition to the Ross planetary mixing line of industrial mixers. The system offers a robust combination of kneading and high shear input and delivers efficient processing power for new generation batteries, adhesives, composites, pharmaceuticals, coatings, and chemicals.
Available in sizes upwards of 1000 gallons, the PDDM system includes a planetary dual disperser complete with an advanced dual-post discharge system suited for 100-psig discharge pressure. In the two systems pictured, the semi-continuous mixing and discharge operation uses 10 interchangeable vessels. Each PDDM is equipped with two rectangular stirrers and two dual-blade, high-speed dispersers that rotate on their own axis while orbiting the mixing zone on a common axis. Operator controls feature a 20-step, 20-recipe program ensuring batch-to-batch consistency and complete traceability.
Articles in this issue
about 7 years ago
Playbooks Are Not Just Child’s Playabout 7 years ago
New Line of Rotary Valvesabout 7 years ago
Updated Pump Headabout 7 years ago
FDA Revamps Biosimilar Quality Requirementsabout 7 years ago
Plate Reader Offers Real-Time Detection and Analysisabout 7 years ago
Automating Quality Checksabout 7 years ago
Considerations for Sterile Filtration of Biologic Drugsabout 7 years ago
Gene Therapies Propel Outsourcing Investmentabout 7 years ago
A Biologics Partisan DivideRelated to this article
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Karthik Iyer, Eli Lilly, details an AI system linking GMP findings, audits, and deviations for cited, inspection-ready regulatory intelligence.
At the PDA/FDA Joint Regulatory Conference 2026, Helen Motamen, MS
global head, Sanofi Quality Audit, Inspection, Intelligence & Advocacy, at Sanofi, provided advice for creating a strong internal audit program.
At PDA/FDA Joint Regulatory Conference 2026, PCI Pharma's Bassler details how a QMS overhaul turned an FDA 483 into stronger quality culture.
Trending on Pharmaceutical Technology
1
Driving Quality Culture to Manage Risk: Lessons from an FDA Inspection Response
2
FDA's IND Pilot Puts CMC Review First
3
Mature Medicines Divestment Signals Shift in Manufacturing Strategy
4
Spray Drying Capacity Signals Faster Paths for Poorly Soluble Drugs
5